Isolation of Hafnia paralvei co-harbouring blaNDM-1 and blaVIM-1 in a woman who underwent allogeneic hematopoietic stem cell transplantation.
-
Authors
-
-
Appel, Tobias Manuel1, 2
-
Stein, Claudia3
-
Brandt, Christian3
-
Rödel, Jürgen4
-
Frietsch, Jochen J5
-
Miethke, Jenny5
-
Hochhaus, Andreas5
-
Hilgendorf, Inken5
-
1
Klinik für Innere Medizin II, Abteilung für Hämatologie und internistische Onkologie, Universitätsklinikum Jena, Kastanienstraße 1, 07747, Jena, Germany. [email protected].
,
(Germany)
-
2
Medizinische Klinik 2, Infektiologie, Universitätsklinikum Frankfurt, Theodor-Stern-Kai 7, 60590, Frankfurt am Main, Germany. [email protected].
,
(Germany)
-
3
Institut für Infektionsmedizin und Krankenhaushygiene, Universitätsklinikum Jena, Kastanienstraße 1, 07747, Jena, Germany.
,
(Germany)
-
4
Institut für Medizinische Mikrobiologie, Universitätsklinikum Jena, Kastanienstraße 1, 07747, Jena, Germany.
,
(Germany)
-
5
Klinik für Innere Medizin II, Abteilung für Hämatologie und internistische Onkologie, Universitätsklinikum Jena, Kastanienstraße 1, 07747, Jena, Germany.
,
(Germany)
- Type
- Published Article
- Journal
-
Infection
- Publisher
-
Springer-Verlag
- Publication Date
-
Aug 01, 2023
- Volume
-
51
- Issue
-
4
- Pages
-
1161–1164
- Identifiers
-
DOI: 10.1007/s15010-022-01976-8
-
PMID: 36595211
- Source
-
Medline
- Keywords
-
- Language
-
English
- License
-
Unknown
Abstract
Metallo-β-lactamases (MBL) are a threat to public health, since they dramatically limit the use of β-lactams. We report the isolation of a multidrug-resistant Hafnia paralvei strain from urine and a rectal swab of a female patient after allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome. Antimicrobial susceptibility testing yielded resistance to trimethoprim/sulfamethoxazole, colistin, fosfomycin and all β-lactams, except cefiderocol. Whole genome sequencing revealed the presence of plasmid-encoded NDM-1 and VIM-1 carbapenemases. This finding highlights the importance of epidemiological surveillance and new therapeutic options for MBL. © 2023. The Author(s).
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
This record was last updated on 07/27/2023 and may not reflect the most current and accurate biomedical/scientific data available from NLM.
The corresponding record at NLM can be accessed at
https://www.ncbi.nlm.nih.gov/pubmed/36595211
Report this publication